1. Home
  2. TDW vs CPRX Comparison

TDW vs CPRX Comparison

Compare TDW & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tidewater Inc.

TDW

Tidewater Inc.

HOLD

Current Price

$76.76

Market Cap

2.8B

ML Signal

HOLD

Logo Catalyst Pharmaceuticals Inc.

CPRX

Catalyst Pharmaceuticals Inc.

HOLD

Current Price

$23.23

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TDW
CPRX
Founded
1956
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
3.0B
IPO Year
N/A
2006

Fundamental Metrics

Financial Performance
Metric
TDW
CPRX
Price
$76.76
$23.23
Analyst Decision
Hold
Strong Buy
Analyst Count
3
1
Target Price
$82.00
$35.00
AVG Volume (30 Days)
879.9K
1.1M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
28.24
EPS
N/A
1.68
Revenue
N/A
$119,072,803.00
Revenue This Year
$1.12
$8.00
Revenue Next Year
$5.56
$9.77
P/E Ratio
$24.08
$13.91
Revenue Growth
N/A
16.39
52 Week Low
$31.17
$19.05
52 Week High
$88.99
$26.56

Technical Indicators

Market Signals
Indicator
TDW
CPRX
Relative Strength Index (RSI) 54.17 41.69
Support Level $47.73 $22.46
Resistance Level $82.00 $24.86
Average True Range (ATR) 4.03 0.97
MACD -1.06 -0.11
Stochastic Oscillator 16.37 28.16

Price Performance

Historical Comparison
TDW
CPRX

About TDW Tidewater Inc.

Tidewater Inc provides marine and transportation services to the offshore energy industry. The company's vessels and associated services support all phases of offshore crude oil and natural gas (also referred to as oil and gas) exploration activities, field development, production, and maintenance, as well as windfarm development and maintenance. Its services include towing and anchor handling for mobile offshore drilling units; transporting supplies and personnel necessary to sustain drilling, workovers, production activities, field abandonment, dismantlement, and restoration activities; and Others. The group manages its business through five segments including the Americas, Asia Pacific, Middle East, Europe/Mediterranean, and West Africa.

About CPRX Catalyst Pharmaceuticals Inc.

Catalyst Pharmaceuticals Inc is a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare and difficult to treat diseases. The Company sells three commercial stage drug products, FIRDAPSE (amifampridine), AGAMREE (vamorolone), and FYCOMPA (perampanel). The Company is currently seeking to further expand its product portfolio, with a focus on acquiring the rights to immediately and near-term accretive assets to treat rare (orphan) diseases across therapeutic areas, including clinical-stage opportunities with established proof of concept.

Share on Social Networks: